SCHEMBL3170404

SCHEMBL3170404

[CH]=CCCCCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3176431 1.00 LMNA (0.38)
SCHEMBL4873474 1.00 LMNA (0.38)
SCHEMBL8433131 1.00 LMNA (0.38)
SCHEMBL4872961 1.00 LMNA (0.38)
SCHEMBL3331317 1.00 LMNA (0.38)
SCHEMBL8433135 1.00 LMNA (0.38)
SCHEMBL3046759 1.00 LMNA (0.38)
SCHEMBL8433677 1.00 LMNA (0.38)
SCHEMBL4874291 1.00 LMNA (0.38)
SCHEMBL3174948 1.00 LMNA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023068322-A1 CD RING SIDE CHAIN-SUBSTITUTED VITAMIN D DERIVATIVE 学校法人帝京大学 2023-04-27 WO disclosed
US-20100011656-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS BASF SE (DE) 2010-01-21 US disclosed
US-20090124732-A1 Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups BASF AKTIENGESELLSCHAFT (DE) 2009-05-14 US disclosed
US-7521556-B2 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides BASF SE (DE) 2009-04-21 US disclosed
CN-101389737-A Use of polynuclear phenolic compounds as stabilisers BASF SE (DE) 2009-03-18 CN disclosed
EP-2007857-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS BASF SE (DE) 2008-12-31 EP disclosed
US-7378551-B2 Amide compound KAO CORPORATION (JP) 2008-05-27 US disclosed
EP-1513841-B1 1,6,9,14-TETRASUBSTITUTED TERRYLENE TETRACARBOXYLIC ACID DIIMIDES BASF SE (DE) 2008-05-14 EP disclosed
CN-101068790-A Rylene tetracarboxylic acid diimides substituted by cyclic amino groups BASF AG (DE) 2007-11-07 CN disclosed
WO-2007099059-A1 USE OF RYLENES AS MARKERS FOR LIQUIDS BASF SE (DE) 2007-09-07 WO disclosed
US-4100355-A 8β,12α-PGE2 -type compounds THE UPJOHN COMPANY (US) 1978-07-11 US disclosed
US-4097675-A 8β, 12α, 15β-PGF2α Compounds THE UPJOHN COMPANY (US) 1978-06-27 US disclosed
US-4096342-A 8β,12α,15β-PGE2 compounds THE UPJOHN COMPANY (US) 1978-06-20 US disclosed
US-4095036-A 8β,12α,15β-PGF2 β Compounds THE UPJOHN COMPANY (US) 1978-06-13 US disclosed
US-4084063-A PROSTAGLANDINS; ANTIULCER AGENTS, ANTICOAGULANTS, OXYTOCICS, DECONGESTANTS THE UPJOHN COMPANY (US) 1978-04-11 US disclosed
US-4059576-A CARDIOVASCULAR, OXYTOCICS HOFFMANN-LA ROCHE, INC. (US) 1977-11-22 US disclosed
US-4052446-A OXYTOCICS, CARDIOVASCULAR AGENTS HOFFMANN-LA ROCHE INC. (US) 1977-10-04 US disclosed
US-4036871-A CARDIOVASCULAR AGENTS, LABOR INDUCERS, ABORTION HOFFMANN-LA ROCHE INC. (US) 1977-07-19 US disclosed
US-3987085-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1976-10-19 US disclosed
US-3969396-A 8β, 11β, 12α-PGE2 compounds THE UPJOHN COMPANY (US) 1976-07-13 US disclosed